Aclaris Therapeutics Inc. | Mutual Funds
Mutual Funds that own Aclaris Therapeutics Inc.
Polar Capital Funds Plc - Healthcare Opportunities Fund
1,400,715
4.51%
0
1.27%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,182,188
3.82%
94,100
0.81%
06/30/2018
Fidelity Select Biotechnology Portfolio
926,801
2.99%
0
0.16%
07/31/2018
Franklin Biotechnology Discovery Fund
700,262
2.25%
63,100
0.77%
03/31/2018
Franklin Small Cap Growth Fund
700,216
2.25%
25,400
0.37%
03/31/2018
Vanguard Total Stock Market Index Fund
637,094
2.06%
0
0%
07/31/2018
Fidelity Small Cap Growth Fund
565,525
1.83%
188,340
0.2%
04/30/2018
iShares Russell 2000 ETF
559,279
1.81%
-300
0.02%
09/06/2018
Invesco Global Health Care Fund
391,396
1.26%
0
0.45%
06/29/2018
iShares Nasdaq Biotechnology ETF
356,394
1.14%
-4,662
0.06%
09/06/2018
| Address |
640 Lee Road
Malvern Pennsylvania 19087
United States
|
|
Employees
|
- |
| Website |
http://www.aclaristx.com |
| Updated |
07/08/2019 |
| Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address unmet needs in medical and aesthetic dermatology and immunology. It operates thrpough Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. |
